Publication | Open Access
Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma
42
Citations
20
References
2019
Year
Patients with HPV-/p16+ have significantly higher risk of M-site recurrence and could potentially be relevant candidates for clinical trials testing systemic treatments in combination with conventional treatments.
| Year | Citations | |
|---|---|---|
Page 1
Page 1